Long-term Mortality After Intensive Care Considering Comorbidity and Admission Diagnoses
NCT ID: NCT06234709
Last Updated: 2024-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200000 participants
OBSERVATIONAL
2005-01-01
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate how common comorbidity is in different age groups and which comorbidity that has the greatest impact on mortality considering different admission diagnosis and after the acute phase compared to the general population. Also, how different degrees of comorbidity affect mortality, adjusted for other comorbidities and SAPS 3?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Method of Measuring Comorbidity to Predict Outcome After Intensive Care
NCT04109001
Socioeconomic Factors and Mortality in the Intensive Care Population
NCT06554808
The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome
NCT04542538
COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality
NCT04390074
Factors Associated With Decisions to Withhold or Withdraw Intensive Care
NCT05394961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hospital discharge diagnoses from in-patient care five years preceding the index time for the ICU admission were extracted from the National Patient Register (NPR) and linked to ICU admissions using unique person identity numbers. Follow-up for all-cause mortality were extracted from the cause of death register at NPR.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Anna Aronsson
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anna Aronsson
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Aronsson Dannewitz, med mag
Role: PRINCIPAL_INVESTIGATOR
Uppsala university department of surgical sciense
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uppsala university department of surgical sciences
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Aronsson Dannewitz A, Svennblad B, Michaelsson K, Lipcsey M, Gedeborg R. The long-term conditional mortality rate in older ICU patients compared to the general population. Crit Care. 2024 Nov 14;28(1):368. doi: 10.1186/s13054-024-05147-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Anna Aronsson Dannewitz
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.